Alx Oncology Holdings Inc
ALXO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001810182
In the last 90 days, Alx Oncology Holdings Inc insiders filed 0 open-market purchases and 2 sales; 93 institutions reported holding it in 13F filings for Q2 2026, worth $217.9M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Alx Oncology Holdings Inc changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 99 | 1 | 87 | −11 |
| Shares | 36.4M | 359 | 36.4M | −5.60K (0.0%) |
| Value | $348.7M | $3.00K | $410.6M | +$61.9M (+17.7%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Alx Oncology Holdings Inc at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Braidwell LP | 258,280 | $2.91M | 0.10% |
| Trexquant Investment LP | 16,749 | $188.8K | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 10,489 | $118.2K | 0.00% |
| UBS Group AG | 7,242 | $81.6K | 0.00% |
| Red Tortoise LLC | 196 | $2.21K | 0.00% |
| Point72 Middle East FZE | 192 | $2.16K | 0.00% |
| Simplex Trading, LLC | 57 | $0 | 0.00% |
Sold out (18)
Institutions that held Alx Oncology Holdings Inc at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Oasis Management Co Ltd. | 106,746 | $1.02M |
| SG Americas Securities, LLC | 50,536 | $484.0K |
| Wellington Management Group LLP | 47,586 | $455.0K |
| Voloridge Investment Management, LLC | 46,070 | $441.0K |
| Marshall Wace, LLP | 24,177 | $231.0K |
| Occudo Quantitative Strategies LP | 23,332 | $223.0K |
| Qube Research & Technologies Ltd | 19,686 | $188.0K |
| BNP Paribas Arbitrage, SA | 17,380 | $166.3K |
| Schonfeld Strategic Advisors LLC | 17,400 | $166.0K |
| Dynamic Technology Lab Private Ltd | 16,340 | $157.0K |
| Gsa Capital Partners LLP | 16,114 | $154.0K |
| Jane Street Group, LLC | 15,033 | $144.0K |
| HC Advisors, LLC | 13,933 | $133.0K |
| Squarepoint Ops LLC | 13,615 | $130.0K |
| Denali Advisors LLC | 7,500 | $72.0K |
| EDBI Pte Ltd | 5,613 | $54.0K |
| Point72 Hong Kong Ltd | 916 | $9.00K |
| US Bancorp | 65 | $1.00K |
Not filed for Q4 2022 yet (1)
Institutions that held Alx Oncology Holdings Inc at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Wipfli Financial Advisors LLC, | 359 | $3.00K |